Therapy Watch delivers updated report from global lupus tracker
The latest report presents a view of the systemic lupus erythematosus (SLE) and lupus nephritis (LN) markets capturing the impact of new product launches. This multi-country study, conducted with rheumatologists and nephrologists, reports on patients with SLE and LN who were on B-cell depleters or immunosuppressants.
Lupus is a complex, chronic, and often invisible autoimmune disease that can severely impact quality of life. It is thought to affect at least five million people worldwide, with around 16,000 new cases each year in the US alone.
This patient record form tracker, helps our clients to understand the dynamics of the market, including initiation vs. maintenance therapy choice, drivers for prescribing, patient demographics, market shares, treatment patterns, and source of business.
Therapy Watch is a syndicated market tracking tool that provides marketing teams, brand managers and market researchers with real-world evidence into prescribing behaviors and market dynamics.
Other insights.
Jump to a slide with the slide dots.
Getting their lives back – Improving options for people with lupus
Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate lupus from the perspective of HCPs and patients.
Read moreMark Hollis re-joins Therapy Watch as a Research Director
We are delighted to announce that Mark Hollis has re-joined Therapy Watch as a Research Director. Mark will support TW’s COVID and Rheumatology.
Read moreOur syndicated services portfolio has expanded
Watch this short video to find out more about our syndicated services: Living With and Therapy Watch.
Read moreSign up to receive Rapport.
Rapport is our monthly newsletter where we share our latest expertise and experience.